lei zhang - Nanotechnology

Author Information

Lei Zhang is affiliated with the Department of Chemical Engineering and the Waterloo Institute for Nanotechnology at the University of Waterloo, located at 200 University Avenue West, Waterloo, ON N2L3G1, Canada. Lei Zhang has an extensive background in nanotechnology and chemical engineering, contributing significantly to the field through various research projects and publications.

Research Contributions

Lei Zhang has made substantial contributions to the understanding and treatment of pulmonary fibrosis, as well as advancements in targeted drug delivery systems. Notable works include studies on methyl-CpG-binding domain 2 and its role in pulmonary fibrosis, the use of RNA nanoparticles for targeted cancer drug delivery, and the modulation of macrophage polarization through siRNA-loaded liposomes. Lei Zhang's research spans various domains including pulmonary diseases, nanomedicine, and chemical engineering processes.

Aliases

There are no aliases provided for Lei Zhang.

Publication and Citation Metrics

Metrics	Values
Total Citation Count	974
H-index	18
Total Paper Count	44

Publications:

The methyl-CpG-binding domain 2 facilitates pulmonary fibrosis by orchestrating fibroblast to myofibroblast differentiation.

DOI: 10.1183/13993003.03697-2020

Year: 2022

Tartrate-resistant acid phosphatase 5 promotes pulmonary fibrosis by modulating β-catenin signaling

DOI: 10.1038/s41467-021-27684-9

Year: 2022

Targeted delivery of cancer drug paclitaxel to chordomas tumor cells via an RNA nanoparticle harboring an EGFR aptamer.

DOI: 10.1016/j.colsurfb.2022.112366

Year: 2022

Optimal Ratio of Methyldiethanolamine and Monoethanolamine Based on Regenerative Energy and Absorption Capacity Analysis

DOI:

Year: 2021

Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis

DOI: 10.7150/thno.48152

Year: 2021

Macrophage‐targeted delivery of siRNA to silence Mecp2 gene expression attenuates pulmonary fibrosis

DOI: 10.1002/btm2.10280

Year: 2021

The cryogenic control system of SHINE

DOI: 10.1140/epjti/s40485-021-00066-7

Year: 2021

Correction: IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages.

DOI: 10.1038/s41418-020-00721-8

Year: 2021

A simplified semi-empirical model for modeling of CO2 solubilities in aqueous MDEA and MEA solutions

DOI: 10.1016/j.fluid.2021.113352

Year: 2021

Indirubin alleviates bleomycin-induced pulmonary fibrosis in mice by suppressing fibroblast to myofibroblast differentiation.

DOI: 10.1016/j.biopha.2020.110715

Year: 2020

What are the Advantages of Quantum Dot Imaging?

What Are the Limitations of Scroll Pumps?

How are Aqueous Suspensions Prepared?

What is the Future of Simulations in Nanotechnology?

What is Nano Simulation?

What are the Common Evaluation Criteria?

Why are Finite Elements Important in Nanotechnology?

What is Feedback Control?

What are Nanotechnology Pilot Programs?

What are the Benefits of Effective Reporting and Recordkeeping?

Partnered Content Networks

Relevant Topics